宣泰医药：关于公司产品拟中选国家药品接续采购的公告

Group 1 - The core point of the article is that Xuantai Pharmaceutical announced its participation in the national organized procurement for drugs whose agreements have expired, specifically regarding the procurement of ursodeoxycholic acid capsules [2] - The company received notification from the procurement office on February 10, 2026, indicating that its product is proposed to be selected in the continuation of the procurement process [2]